EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Leukotriene receptor antagonist drugs as potential chemopreventive agents: A systematic review and meta-analysis of cancer risk in asthmatic patients

Francisco Cezar Aquino de Moraes, Luis Henrique Rios Moreira Rego, Rommel Mario Rodríguez Burbano, Mario Hiroyuki Hirata

Prostaglandins, Leukotrienes and Essential Fatty Acids · 2026-07 · 209 · 102732

DOI: 10.1016/j.plefa.2026.102732 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Prostaglandins, Leukotrienes and Essential Fatty Acids, 2026-07. Verfasst von Francisco Cezar Aquino de Moraes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Toxicological Analyses, University of Sao Paulo, Sao Paulo 05508-000 Brazil. Electronic address: francisco.cezar2205@gmail…. Hauptthemen laut MEDLINE: Leukotriene Antagonists, Asthma, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation represents a critical factor in carcinogenesis, and cysteinyl leukotrienes (CysLTs) have been associated with tumor development and progression. Thus, it has been hypothesized that leukotriene receptor antagonists (LTRAs), widely used in the treatment of asthma, could exert a chemopreventive effect due to the modulation of inflammatory pathways. However, the association between LTRAs and cancer risk among asthma patients is still not fully understood. Medline, Scopus, Web of Science, and the Cochrane Library were searched from inception to August 2, 2025 for studies including patients with asthma that have used LTRAs reporting cancer risk. Statistical analysis was made in R software, with hazard outcomes using hazard ratio (HR) by applying Inverse variance random-effect models. P values

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukotriene AntagonistsAsthmaNeoplasmsHumansRisk FactorsFemale

Stichwörter der Autor:innen

Asthma treatmentCancer riskChemopreventionCysteinyl leukotrienesMeta-analysis

Substanzen

Leukotriene Antagonists

Autor:innen und Institutionen

  • Department of Clinical and Toxicological Analyses, University of Sao Paulo, Sao Paulo 05508-000 Brazil. Electronic address: francisco.cezar2205@gmail.com.
  • Department of Medicine, State University of Piauí, Teresina, 64078-213, Brazil.
  • Ophir Loyola Hospital, Belém, Pará, 66063-240, Brazil.
  • Department of Clinical and Toxicological Analyses, University of Sao Paulo, Sao Paulo 05508-000 Brazil.

Zitieren

APA

de Moraes, F. C. A., Rego, L. H. R. M., Burbano, R. M. R., & Hirata, M. H. (2026). Leukotriene receptor antagonist drugs as potential chemopreventive agents: A systematic review and meta-analysis of cancer risk in asthmatic patients. Prostaglandins, Leukotrienes and Essential Fatty Acids, 209, 102732. https://doi.org/10.1016/j.plefa.2026.102732

Vancouver

de Moraes FCA, Rego LHRM, Burbano RMR, Hirata MH. Leukotriene receptor antagonist drugs as potential chemopreventive agents: A systematic review and meta-analysis of cancer risk in asthmatic patients. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2026;209:102732. doi:10.1016/j.plefa.2026.102732

BibTeX
@article{deMoraes2026,
  author = {de Moraes, Francisco Cezar Aquino and Rego, Luis Henrique Rios Moreira and Burbano, Rommel Mario Rodríguez and Hirata, Mario Hiroyuki},
  title = {Leukotriene receptor antagonist drugs as potential chemopreventive agents: A systematic review and meta-analysis of cancer risk in asthmatic patients},
  journal = {Prostaglandins, Leukotrienes and Essential Fatty Acids},
  year = {2026},
  volume = {209},
  pages = {102732},
  doi = {10.1016/j.plefa.2026.102732}
}
Kostenlos starten →